- Filed
- Oct 29, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 226.5M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 227.7M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 234.3M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 235.6M sh |
| Shares Outstanding | Q3 2025 · Sep 30, 2025 | 224.4M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $687M |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $511M |
| Dividends Paid | Q3 2025 · Sep 30, 2025 | $468M |
| Dividends Paid | Q3 2025 · Sep 30, 2024 | $464M |
| Capex | Q3 2025 · Sep 30, 2025 | $477M |
| Capex restated | Q3 2025 · Sep 30, 2024 | $513M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $1.05B |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $1.07B |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $5.9B |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $4.88B |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $4M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $7M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $76M |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $88M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $1.83B |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $1.27B |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $7.8B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $6.79B |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $5.61B |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $5.01B |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $14.19B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $12.47B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $8.22B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $6.56B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $22.14B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $19.43B |
| Total Assets | Q3 2025 · Sep 30, 2024 | $21.86B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $2.00 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $5.60 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $2.00 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $5.93 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $2.01 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $5.62 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $2.01 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $5.96 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $824M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $2.53B |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $848M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $2.56B |
| Net Income | Q3 2025 · Sep 30, 2025 | $453M |
| Net Income | Q3 2025 · Sep 30, 2025 | $1.28B |
| Net Income | Q3 2025 · Sep 30, 2024 | $468M |
| Net Income | Q3 2025 · Sep 30, 2024 | $1.4B |
| Operating Income | Q3 2025 · Sep 30, 2025 | $689M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $2.04B |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $689M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $2.15B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $2.43B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $7B |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $2.38B |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $7.04B |
| Revenue | Q3 2025 · Sep 30, 2025 | $4.08B |
| Revenue | Q3 2025 · Sep 30, 2025 | $11.96B |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $4.03B |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $12.12B |